Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer
NCT02534922
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Ovarian Cancer
Peritoneal Cancer
Fallopian Tube Cancer
Interventions
BIOLOGICAL:
Prolanta, a human prolactin receptor antagonist
Sponsor
Oncolix, Inc.